$NKE

Nike: Shares fall, S&P 100 ejection and Mbappe out

Nike's shares fell after the company reported a 4% revenue decline to $11.2bn and a 2% net income drop to $712m in Q1, citing challenges in China. The company is restructuring and was removed from the S&P 100. Nike's market cap is $52bn, but it faces increased competition. CEO Elliott Hill acknowledged pressures in key business areas.

Original reporting
Published Oct 2, 2026, 10:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 10:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nike: Shares fall, S&P 100 ejection and Mbappe out — source image
Decision brief

The 30-second read

$NKEBearishHigh
01

Why it matters

The guidance downgrade and index ejection are likely to trigger short‑term selling pressure, but the restructuring plan may mitigate longer‑term risks.

02

Market read

Nike’s guidance cut is a material event for the consumer discretionary sector and could affect related apparel stocks.

03

What to watch

Potential upside from new leadership (Alexandre Arnault) and any undisclosed cost‑saving measures.

Relevance 8/10Novelty 8/10Timing: today

Background

Nike, the world’s largest sportswear brand, reported a 4% revenue drop to $11.2 bn and a 2% net‑income decline, while being removed from the S&P 100.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Nike disclosed a revenue decline and lower net income for the upcoming year, plus ejection from the S&P 100 and a restructuring plan.

Expected impact

downward pressure as investors price in weaker revenue and earnings outlook

Evidence & confidence

Large-cap with billions in revenue; guidance decline is material and fresh, prompting immediate sell side activity.

Market effects

Potential drag on consumer discretionary and apparel sector as peers may face similar demand pressures.

U.S. market may see modest pullback in retail exposure; Asian markets could feel secondary effects from China slowdown.

Nike's size means its guidance cut can influence global consumer sentiment and index composition.

Counterpoint

If the restructuring succeeds, long-term margins could improve, offering a buying opportunity at depressed prices.

Key entities

  • Nike

    U.S.-listed sportswear giant (ticker NKE).

  • Alexandre Arnault

    New hire from LVMH tasked with turning around Nike’s performance.

Related articles

$NKEMed

Nike's struggles test investor confidence in CEO Hill's turnaround effort

Nike's CEO Elliott Hill faces investor skepticism as the company's market value and earnings have halved since his return. Nike announced job cuts and forecast steeper sales and profit declines for fiscal 2028, with savings expected in fiscal 2029-2030. Challenges include weak performance in China, sportswear, and the Jordan brand, which together account for over half of total sales. Shares dropped 10% in premarket trading on Friday, reaching a 12-year low.

$NKEMed

Guggenheim cuts Nike stock price target to $50 on guidance concerns

Guggenheim cut Nike's (NKE) price target to $50 from $60, citing weak guidance despite EPS beats. Revenue missed estimates due to China weakness. NKE shares fell 9%, trading near 52-week lows. Analysts revised earnings down, but some see undervaluation. Management's guidance was below consensus. Other analysts also lowered targets, citing revenue and earnings pressures, especially in China.

$NKEHighAI 9/10

Nike Stock Tumbles After Weak Fiscal 2027 Outlook

Nike (NKE) shares dropped 10% after lowering fiscal 2027 outlook due to weak China demand. Q1 revenue fell 4% to $11.2B, net income declined 2% to $712M. Greater China revenue dropped 22%. Nike expects fiscal 2027 revenue to decline by a high-single-digit percentage, with adjusted EPS projected at $1.15-$1.35.

$NKEHighAI 9/10

Premarket movers: ike tumbles 10%, Synaptics jumps on $5.7B deal

Nike (NKE) fell 9.6% premarket after mixed Q1 results and weak FY guidance. Synaptics (SYNA) rose 13.8% following a revised $5.7B all-cash acquisition deal by onsemi (ON). Moderna (MRNA) gained 2.2% on Nasdaq-100 inclusion. Fair Isaac (FICO) dropped 6.9% on FHFA mortgage data report. MicroStrategy (MSTR) rose 2.7% after Citi raised its price target.